Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2015

Aug 19, 2015

30339_dirs_2015-08-19_e7ceafa5-8cba-4146-ada1-87616f55189c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2015-08-17

Reporting Person: FEDERICI WILLIAM J (Sr. VP & CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-08-17 Common Stock M 52678.0000 $22.4850 Acquired 256359.6826 Direct
2015-08-17 Common Stock S 52678.0000 $59.7237 Disposed 203681.6826 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-08-17 Stock Option (Right to Buy) $22.4850 M 52678.0000 Disposed 2018-02-27 Common Stock (52678.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1025.5654 Indirect
Common Stock 16274.1276 Indirect

Footnotes

F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.